On Air Now

Upcoming Shows

Program Schedule »

Tune in to Listen

650 AM Hibbing, Minnesota

Weather

Current Conditions(Hibbing,MN 55746)

More Weather »
58° Feels Like: 58°
Wind: N 3 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Clear 50°

Tomorrow

Mostly Sunny 75°

Thurs Night

Mostly Clear 46°

Alerts

Merck and Endocyte's ovarian cancer drug fails in trial

(Reuters) - Merck & Co Inc and Endocyte Inc said they had stopped a late-stage trial of their experimental ovarian cancer drug because it did not improve survival rates without the cancer worsening.

The trial was testing the drug, vintafolide, in combination with a chemotherapy drug, pegylated liposomal doxorubicin (PLD), compared to PLD plus a placebo.

An independent safety committee reviewing the trial had recommended that it be halted, the companies said in separate statements.

(Reporting by Esha Dey in Bangalore; Editing by Maju Samuel)

Comments